FIND

researchers

DISCOVER

relevant articles

PROMOTE

your research

now for free

Cecilia Hindorf

Research Profile

Procedures

Radioimmunotherapy

Devices

Radiometry

Chemicals & Drugs

Concepts & Ideas

Co-author Network

Publications

TOP 3
Jenny Oddstig; Marcus Carlsson; Fredrik Hedeer; Cecilia Hindorf; Jonas Jögi; Henrik Engblom
Reduced administered activity, reduced acquisition time, and preserved image quality for the new CZT camera.
Cecilia Hindorf; Chris Parker; Anne-Kirsti Aksnes; Sarah Chittenden; Glenn D Flux
Quantitative imaging of 223Ra-chloride (Alpharadin) for targeted alpha-emitting radionuclide therapy of bone metastases.
Nadège Anizan; Jacques Barbet; Thomas Carlier; Cecilia Hindorf; Manuel Bardiès
dAcquisition setting optimization and quantitative imaging for 124I studies with the Inveon microPET-CT system.

Register for free to view:

Visualized networks:

See your personal network in
sophisticated graphical views

GeoTargeted Searches:

Locate experts around the world
and connect with global collaborators

Research Profiles:

See the research activity
of experts around the globe

Geonetwork of Cecilia Hindorf (preview)

Cities where this author has publications
Cities where co-authors of this author have publications

Flash Player Required

All Publications

2013: Jenny Oddstig; Marcus Carlsson; Fredrik Hedeer; Cecilia Hindorf; Jonas Jögi; Henrik Engblom
Reduced administered activity, reduced acquisition time, and preserved image quality for the new CZT camera.
Journal of nuclear cardiology : official publication of the American Society of Nuclear Cardiology 2013;20(1):38-44.
2012: Cecilia Hindorf; Chris Parker; Anne-Kirsti Aksnes; Sarah Chittenden; Glenn D Flux
Quantitative imaging of 223Ra-chloride (Alpharadin) for targeted alpha-emitting radionuclide therapy of bone metastases.
Nuclear medicine communications 2012;33(7):726-32.
2012: Nadège Anizan; Jacques Barbet; Thomas Carlier; Cecilia Hindorf; Manuel Bardiès
dAcquisition setting optimization and quantitative imaging for 124I studies with the Inveon microPET-CT system.
EJNMMI research 2012;2():7.
2012: Lucile Tran; Nadège Dartial; Cecilia Hindorf; Georges VASSAUX
In vivo positron emission tomography imaging using the sodium iodide symporter as a reporter gene.
Methods in molecular biology (Clifton, N.J.) 2012;797():89-96.
2010: Cecilia Hindorf; Gerhard Glatting; Carlo Chiesa; Ola Lindén; Glenn Flux
EANM Dosimetry Committee guidelines for bone marrow and whole-body dosimetry.
European journal of nuclear medicine and molecular imaging 2010;37(6):1238-50.
2010: Glenn D Flux; Masud Haq; Sarah J Chittenden; Susan Buckley; Cecilia Hindorf; Kate Newbold; Clive L Harmer
A dose-effect correlation for radioiodine ablation in differentiated thyroid cancer.
European journal of nuclear medicine and molecular imaging 2010;37(2):270-5.
2008: Michael Lassmann; Heribert Hänscheid; Carlo Chiesa; Cecilia Hindorf; Glenn Flux; Markus Luster
EANM Dosimetry Committee series on standard operational procedures for pre-therapeutic dosimetry I: blood and bone marrow dosimetry in differentiated thyroid cancer therapy.
European journal of nuclear medicine and molecular imaging 2008;35(7):1405-12.
2007: Cecilia Hindorf; Dimitris Emfietzoglou; Ola Lindén; Christos Bousis; Andreas Fotopoulos; Kostas Kostarelos; Glenn D Flux
Single-cell dosimetry for radioimmunotherapy of B-cell lymphoma patients with special reference to leukemic spread.
Cancer biotherapy & radiopharmaceuticals 2007;22(3):357-66.
2007: Maria Holstensson; Cecilia Hindorf; Michael Ljungberg; Mike Partridge; Glenn D Flux
Optimization of energy-window settings for scatter correction in quantitative (111)In imaging: comparison of measurements and Monte Carlo simulations.
Cancer biotherapy & radiopharmaceuticals 2007;22(1):136-42.
2007: Cecilia Hindorf; Sarah Chittenden; Louise Causer; Val J Lewington; Helmut R Mäcke; Glenn D Flux
Dosimetry for (90)Y-DOTATOC therapies in patients with neuroendocrine tumors.
Cancer biotherapy & radiopharmaceuticals 2007;22(1):130-5.
2005: Ola Lindén; Cecilia Hindorf; Eva Cavallin-Ståhl; William A Wegener; David M Goldenberg; Heather Horne; Tomas Ohlsson; Lars Stenberg; Sven-Erik Strand; Jan Tennvall
Dose-fractionated radioimmunotherapy in non-Hodgkin's lymphoma using DOTA-conjugated, 90Y-radiolabeled, humanized anti-CD22 monoclonal antibody, epratuzumab.
Clinical cancer research : an official journal of the American Association for Cancer Research 2005;11(14):5215-22.
2005: Cecilia Hindorf; Dimitris Emfietzoglou; Ola Lindén; Kostas Kostarelos; Sven-Erik Strand
Internal microdosimetry for single cells in radioimmunotherapy of B-cell lymphoma.
Cancer biotherapy & radiopharmaceuticals 2005;20(2):224-30.
2005: Cecilia Hindorf; Ola Lindén; Jan Tennvall; Karin Wingårdh; Sven-Erik Strand
Evaluation of methods for red marrow dosimetry based on patients undergoing radioimmunotherapy.
Acta oncologica (Stockholm, Sweden) 2005;44(6):579-88.
2004: Cecilia Hindorf; Michael Ljungberg; Sven-Erik Strand
Evaluation of parameters influencing S values in mouse dosimetry.
Journal of nuclear medicine : official publication, Society of Nuclear Medicine 2004;45(11):1960-5.
2003: Cecilia Hindorf; Ola Lindén; Lars Stenberg; Jan Tennvall; Sven-Erik Strand
Change in tumor-absorbed dose due to decrease in mass during fractionated radioimmunotherapy in lymphoma patients.
Clinical cancer research : an official journal of the American Association for Cancer Research 2003;9(10 Pt 2):4003S-6S.
2002: Ola Lindén; Cecilia Hindorf; Jan Tennvall; Sverker Segrén; Karin Wingardh; Sven-Erik Strand
Single tumor cell uptake and dosimetry of technetium-99m Fab' or minute anti-CD22 in low-grade B-cell lymphoma.
Cancer 2002;94(4 Suppl):1270-4.
2002: Cecilia Hindorf; Ola Lindén; Jan Tennvall; Karin Wingårdh; Sven-Erik Strand
Time dependence of the activity concentration ratio of red marrow to blood and implications for red marrow dosimetry.
Cancer 2002;94(4 Suppl):1235-9.
2002: Ola Lindén; Jan Tennvall; Cecilia Hindorf; Eva Cavallin-Ståhl; Karl-Johan Lindner; Tomas Ohlsson; Karin Wingårdh; Sven-Erik Strand
131I-labelled anti-CD22 MAb (LL2) in patients with B-cell lymphomas failing chemotherapy. Treatment outcome, haematological toxicity and bone marrow absorbed dose estimates.
Acta oncologica (Stockholm, Sweden) 2002;41(3):297-303.
1999: Michael Garkavij; Jan Tennvall; Tomas Ohlsson; Lars Lindgren; Cecilia Hindorf; Hans Sjögren; Sven-Erik Strand
Comparison of 125I- and (111)In-labeled monoclonal antibody BR96 for tumor targeting in combination with extracorporeal immunoadsorption.
Clinical cancer research : an official journal of the American Association for Cancer Research 1999;5(10 Suppl):3059s-3064s.
1997: J Q Chen; Sven-Erik Strand; Jan Tennvall; Lars Lindgren; Cecilia Hindorf; Hans Sjögren
Extracorporeal immunoadsorption compared to avidin chase: enhancement of tumor-to-normal tissue ratio for biotinylated rhenium-188-chimeric BR96.
Journal of nuclear medicine : official publication, Society of Nuclear Medicine 1997;38(12):1934-9.